glp-1 receptor agonist and dpp-4 inhibitor combination not recommended do combine inhibitors with agonists guidance Why are DPP-4 ( GLP-1 receptor agonist versus DPP-4
Description
PMID: 16406191
Small studies have suggested a parallel reduction in intrapancreatic fat content following initiation of GLP-1RA 52
Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
Conversely, patients with long-standing obesity, multiple previous weight loss attempts, or significant metabolic dysfunction may benefit from indefinite therapy
When blood sugar is high, GIP has minimal effect on glucagon
We'll also explore diagnostic methods and management strategies to help practitioners and patients handle these potentially dangerous complications effectively
